Prostate Cancer Treatment and Research
Description: This cluster of papers represents a comprehensive exploration of advancements in prostate cancer research, covering topics such as androgen receptor signaling, genomic profiling, hormone therapy, immunotherapy, genetic mutations, clinical trials, biomarkers, and molecular biology. The papers discuss the molecular determinants of resistance to antiandrogen therapy, the impact of translocations and gene fusions on cancer causation, and the development of second-generation antiandrogens for the treatment of advanced prostate cancer.
Characteristic keywords: castration-resistant prostate cancer, androgen deprivation therapy, androgen receptor, metastatic prostate cancer, metastatic castration-resistant prostate cancer, abiraterone, enzalutamide, androgen receptor antagonists, LNCaP cells, advanced prostate cancer, PSA response, metastatic hormone-sensitive prostate cancer, prostate adenocarcinoma, androgen receptor signaling, neuroendocrine prostate cancer, prostate cancer progression, prostate cancer treatment, bicalutamide, cabazitaxel, androgen receptor pathway inhibitors, DU145 cells, TMPRSS2-ERG fusion, apalutamide, androgen receptor splice variants, enzalutamide resistance
Sibling topics: MicroRNA in disease regulation, Breast Cancer Treatment Studies, Carcinogens and Genotoxicity Assessment, Cancer-related molecular mechanisms research, Protease and Inhibitor Mechanisms, Cancer, Hypoxia, and Metabolism, Photodynamic Therapy Research Studies, Cancer Genomics and Diagnostics, Ferroptosis and cancer prognosis, NF-κB Signaling Pathways, Cancer, Lipids, and Metabolism, Cancer, Stress, Anesthesia, and Immune Response, Science, Research, and Medicine, Cancer Mechanisms and Therapy, Beetle Biology and Toxicology Studies
Parent subfield: Cancer Research
Domain: Life Sciences
OpenAlex ID: T10543
